Nitrate to prevent kidney injury from contrast dye
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a heart catheterization or a CT scan with contrast dye.
- Your kidney function is lower than normal (based on a recent blood test).
- If you are a woman who could become pregnant, you agree to use effective birth control during the study.
- You can take oral medication and follow the study routine.
- You do not have severe low blood pressure or need medicines to support your blood pressure.
- You are not already on dialysis, have not had a heart attack requiring emergency treatment, and have not had contrast dye in the last 5 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.
This trial tests a beet-derived food product (a natural source of nitrate) to see if it can help prevent kidney damage caused by the contrast dye used during a heart procedure called PCI. It is designed for people who already have a higher risk of this kidney problem.
This trial tests whether drinking extra water during treatment for a heart attack can help prevent kidney damage caused by the heart procedure. If you are eligible, this could be a simple way to protect your kidneys.
This trial tests whether a simple “arm conditioning” technique done remotely before a procedure can help prevent kidney injury caused by contrast dye used during certain heart catheter tests. You might benefit if you’re having a coronary angiogram and your kidney function is reduced, but you’re not on dialysis.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This trial tests whether using a much smaller amount of contrast dye for an invasive heart scan is safer for people with acute kidney injury (AKI). It may help reduce further kidney stress while still allowing doctors to look at coronary (heart) arteries.
Hear when a new Kidney Injury, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.